IR-Med Income Statement (2020-2025) | IRME

Income Statement Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025
Revenue & cost
Cost of Revenue (Quarter) 0.59M0.06M0.06M0.05M0.13M0.02M0.55M0.17M0.16M0.30M0.19M0.17M0.03M0.03M-0.01M0.00M0.00M
Operating items
Research & Development (Quarter) 0.05M0.22M0.10M0.39M0.37M0.55M0.48M0.41M0.47M0.53M0.60M0.50M0.47M0.49M0.20M0.09M0.20M0.22M0.02M0.09M
Selling, General & Administrative (Quarter) 0.03M0.18M0.33M0.53M0.29M0.39M0.33M0.43M0.38M0.98M0.57M0.44M0.43M0.58M0.29M0.24M0.37M0.11M0.23M0.19M
Operating Expenses (Quarter) 0.08M0.39M0.43M0.92M0.66M0.94M0.80M0.84M0.85M1.51M1.18M0.94M0.90M1.07M0.49M0.33M0.57M0.33M0.25M0.28M
Operating Income (Quarter) -0.08M-0.39M-0.43M-1.52M-0.72M-1.00M-0.85M-0.97M-0.88M-2.06M-1.35M-1.10M-1.20M-1.26M-0.66M-0.36M-0.60M-0.32M-0.25M-0.29M
EBIT (Quarter) -0.08M-0.39M-0.43M-1.52M-0.72M-1.00M-0.85M-0.97M-0.88M-2.06M-1.35M-1.10M-1.20M-1.26M-0.66M-0.36M-0.60M-0.32M-0.25M-0.29M
Non-operating items
Non Operating Income (Quarter) -0.01M0.01M-0.01M-0.01M-0.01M-0.01M0.00M0.03M0.02M-0.03M0.00M-0.01M0.02M-0.01M0.00M-0.01M0.00M0.00M-0.52M-0.41M
Net income details
EBT (Quarter) -0.08M-0.39M-0.43M-1.52M-0.72M-1.00M-0.85M-0.97M-0.88M-2.06M-1.35M-1.10M-1.20M-1.26M-0.66M-0.36M-0.60M-0.32M-0.25M-0.29M
Profit After Tax (Quarter) -0.09M-0.40M-0.44M-1.52M-0.73M-1.02M-0.85M-0.94M-0.86M-2.09M-1.35M-1.11M-1.18M-1.27M-0.66M-0.37M-0.60M-0.28M-0.77M-0.70M
Income from Continuing Operations (Quarter) -0.08M-0.39M-0.43M-1.52M-0.72M-1.00M-0.85M-0.97M-0.88M-2.06M-1.35M-1.10M-1.20M-1.26M-0.66M-0.36M-0.60M-0.32M-0.25M-0.29M
Consolidated Net Income (Quarter) -0.08M-0.39M-0.43M-1.52M-0.72M-1.00M-0.85M-0.97M-0.88M-2.06M-1.35M-1.10M-1.20M-1.26M-0.66M-0.36M-0.60M-0.32M-0.25M-0.29M
Income towards Parent Company (Quarter) -0.08M-0.39M-0.43M-1.52M-0.72M-1.00M-0.85M-0.97M-0.88M-2.06M-1.35M-1.10M-1.20M-1.26M-0.66M-0.36M-0.60M-0.32M-0.25M-0.29M
Net Income towards Common Stockholders (Quarter) -0.08M-0.39M-0.43M-1.52M-0.72M-1.00M-0.85M-0.97M-0.88M-2.06M-1.35M-1.10M-1.20M-1.26M-0.66M-0.36M-0.60M-0.32M-0.25M-0.29M
Additional items
EPS (Basic) (Quarter) 0.00-0.01-0.010.02-0.01-0.02-0.01-0.01-0.01-0.03-0.02-0.02-0.02-0.02-0.01-0.01-0.01-0.01-0.01-0.01
EPS (Weighted Average and Diluted) (Quarter) -0.01-0.01-0.03-0.02-0.02-0.02-0.02-0.01-0.01-0.01-0.01-0.01-0.01
Shares Outstanding (Weighted Average) (Quarter) 30.53M30.03M63.98M61.62M64.60M63.11M64.60M66.42M68.72M67.58M68.83M69.03M68.84M69.40M69.93M70.11M70.31M71.01M71.26M72.42M
Shares Outstanding (Diluted Average) (Quarter) 68.72M68.83M68.92M69.23M69.93M70.28M70.76M71.26M72.42M
EBITDA (Quarter) -0.08M-0.39M-0.43M-1.52M-0.72M-1.00M-0.85M-0.97M-0.88M-2.06M-1.35M-1.10M-1.20M-1.26M-0.66M-0.36M-0.60M-0.32M-0.25M-0.29M